These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28382147)

  • 21. Combined bortezomib-based chemotherapy and p53 gene therapy using hollow mesoporous silica nanospheres for p53 mutant non-small cell lung cancer treatment.
    Li C; Hu J; Li W; Song G; Shen J
    Biomater Sci; 2016 Dec; 5(1):77-88. PubMed ID: 27822577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of Decitabine Combined with Bortezomib on the Proliferation of Mantle Cell Lymphoma Cell Lines and Its Underling Mechanisms].
    Zhang JN; Qiao SK; Chen D; Xing LN; Li Y; Guo XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1197-1204. PubMed ID: 32798398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth.
    Xu L; Meng X; Xu N; Fu W; Tan H; Zhang L; Zhou Q; Qian J; Tu S; Li X; Lao Y; Xu H
    Cell Death Dis; 2018 Feb; 9(3):262. PubMed ID: 29449529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gambogenic acid induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the P53 signaling pathway.
    Liu Z; Wang X; Li J; Yang X; Huang J; Ji C; Li X; Li L; Zhou J; Hu Y
    Chem Biol Interact; 2023 Sep; 382():110602. PubMed ID: 37302459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing].
    Yang L; Wang M; Cheng H; Li Q
    Zhongguo Zhong Yao Za Zhi; 2011 May; 36(9):1217-21. PubMed ID: 21842653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic trioxide rewires mantle cell lymphoma response to bortezomib.
    Zhao LL; Liu YF; Peng LJ; Fei AM; Cui W; Miao SC; Hermine O; Gressin R; Khochbin S; Chen SJ; Wang J; Mi JQ
    Cancer Med; 2015 Nov; 4(11):1754-66. PubMed ID: 26310857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STK405759 as a combination therapy with bortezomib or dexamethasone, in
    Rozic G; Paukov L; Cohen Z; Shapira I; Duek A; Bejamini O; Avigdor A; Nagler A; Koman I; Leiba M
    Oncotarget; 2018 Jul; 9(59):31367-31379. PubMed ID: 30140376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin enhances the cytotoxic activity of bortezomib against myeloma cells via suppression of Bcl-2, survivin and phosphorylation of AKT.
    Ding JH; Yuan LY; Chen GA
    Oncol Lett; 2017 Feb; 13(2):647-654. PubMed ID: 28356941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of Bushen Yanggu Decoction on Multidrug Resistance of Multiple Myeloma Cell Line KM3/BTZ].
    Li YP; Zhang JG; Fang ZQ; Huang XR; Chen X; Li ZJ; Fang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):482-488. PubMed ID: 30998158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gambogenic Acid Induces Endoplasmic Reticulum Stress in Colorectal Cancer via the Aurora A Pathway.
    Liu C; Xu J; Guo C; Chen X; Qian C; Zhang X; Zhou P; Yang Y
    Front Cell Dev Biol; 2021; 9():736350. PubMed ID: 34692693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Icaritin Reverses Multidrug Resistance of Multiple Myeloma Cell Line KM3/BTZ].
    Li ZY; Li ZJ; Chen X; Huang XR; Fang ZQ; Zhang JG; Fang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1690-1695. PubMed ID: 29262899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gambogenic acid inhibits proliferation of A549 cells through apoptosis inducing through up-regulation of the p38 MAPK cascade.
    Cheng H; Su JJ; Peng JY; Wang M; Wang XC; Yan FG; Wang XS; Li QL
    J Asian Nat Prod Res; 2011 Oct; 13(11):993-1002. PubMed ID: 22007630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic and Apoptotic Effects of Pinostilbene and Bortezomib Combination Treatment on Human Multiple Myeloma Cells.
    Staskiewicz A; Wong E; Tucker M; Farhin R; Park J; Saade R; Alkhazali T; Dang T; Wang X
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decitabine enhances bortezomib treatment in RPMI 8226 multiple myeloma cells.
    Cao Y; Qiu GQ; Wu HQ; Wang ZL; Lin Y; Wu W; Xie XB; Gu WY
    Mol Med Rep; 2016 Oct; 14(4):3469-75. PubMed ID: 27571872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gambogenic Acid Inhibits Basal Autophagy of Drug-Resistant Hepatoma Cells and Improves Its Sensitivity to Adriamycin.
    Wang M; Zhan F; Cheng H; Li Q
    Biol Pharm Bull; 2022; 45(1):63-70. PubMed ID: 34980780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Apoptosis of melanoma B16 cells induced by gambogenic acid].
    Tan YJ; Zhang X; Cheng H; Li QL
    Zhong Yao Cai; 2014 Mar; 37(3):469-73. PubMed ID: 25174115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer.
    Wang XS; Kong DJ; Lin TY; Li XC; Izumiya Y; Ding XZ; Zhang L; Hu XC; Yang JQ; Gao SG; Lam KS; Li YP
    Acta Pharmacol Sin; 2017 Jun; 38(6):931-942. PubMed ID: 28552907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gambogenic acid inhibits the proliferation of small‑cell lung cancer cells by arresting the cell cycle and inducing apoptosis.
    Huang T; Zhang H; Wang X; Xu L; Jia J; Zhu X
    Oncol Rep; 2019 Mar; 41(3):1700-1706. PubMed ID: 30592285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of miR-21.
    Liu P; Wu X; Dai L; Ge Z; Gao C; Zhang H; Wang F; Zhang X; Chen B
    J Cancer; 2017; 8(16):3278-3286. PubMed ID: 29158801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism.
    Xu Q; Guo J; Chen W
    Biochem Biophys Res Commun; 2019 Jan; 508(3):882-888. PubMed ID: 30538042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.